Dokumendiregister | Ravimiamet |
Viit | REP-1/2185-1 |
Registreeritud | 29.04.2025 |
Sünkroonitud | 30.04.2025 |
Liik | Sissetulev kiri |
Funktsioon | REP Euroopa Farmakopöaga seotud asjaajamine |
Sari | REP-1 Euroopa Farmakopöa alane kirjavahetus |
Toimik | REP-1/2025 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | European Directorate for the Quality of Medicines & HealthCare |
Saabumis/saatmisviis | European Directorate for the Quality of Medicines & HealthCare |
Vastutaja | Signe Leito (RA, Peadirektori asetäitja valdkond, Labor) |
Originaal | Ava uues aknas |
1
Signe Leito
Saatja: [email protected] Saatmisaeg: kolmapäev, 23. aprill 2025 16:43 Adressaat: Signe Leito Teema: Proposal to add a new monograph on Milrinone to the Ph. Eur. work programme: EDQM-2025-01739-mail
Please make sure to include in any reply our mail reference: EDQM-2025-01739-mail **************************************************************************** European Pharmacopoeia Commission Secretariat
RZ/PH/ 2025-01670L SI/mk Strasbourg, 23/04/2025
LETTER FOR THE ATTENTION OF THE NPAs Copy: Presidium
Dear Colleagues
Please find below the link to a survey being carried out concerning the proposed addition of the monograph Milrinone to the work programme of group 10B.
In order to have access to the survey, please copy and paste this link into your Internet browser:
https://survey.edqm.eu/index.php?r=survey/index&sid=932244&lang=en Deadline for replies: 23 May 2025
With kind regards,
On behalf of Sylvina Iossiphova
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
2
Mireille Kopf Secretarial Assistant European Pharmacopoeia Department EDQM - Council of Europe Tel.: +33 (0)3 88 41 28 53 / Fax: +33 (0)3 88 41 27 71 https://www.edqm.eu / https://store.edqm.eu Stay connected with the EDQM **************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2025-01739-mail